| Literature DB >> 35995932 |
Alberta Serwah Anning1, Emmanuel Baah1, Suzzana Dickson Buabeng1, Bernice Gloria Baiden1, Benjamin Aboagye2, Yeboah Kwaku Opoku3, Leslie Larry Afutu4, George Ghartey-Kwansah5.
Abstract
The evidence of rising numbers of multidrug-resistant organisms requires the implementation of effective stewardship programs. However, this should be informed by evidence-based knowledge of local antimicrobial resistance patterns. The current study aims to establish the prevalence of common pathogenic microbes including their antimicrobial susceptibility patterns and distribution in the Cape Coast Metropolis. This was a retrospective study where microbial culture and antimicrobial susceptibility records for 331 patients were reviewed from January to December 2019, at a private health centre. All data were analysed using Excel (Microsoft Office, USA), SPSS and GraphPad Prism 8 software programs. Among the samples tested, 125 (37.76%) were positive for microbes with high vaginal swab (HVS) samples recording the highest number of pathogens (44%), followed by urine (40%) and both pleural and semen samples having the least (0.3% each). Again, gram-negative isolates were more prevalent than the gram-positive isolates. The prevalence of antimicrobial resistance was very significant with isolates resistant to more than one antibiotic (P < 0.05). Escherichia coli showed the highest level of resistance, followed by Citrobacter spp. These were followed by Klebsiella spp., Staphylococcus spp., Coliforms, Pseudomonas spp., Commensals and Candida spp. The high resistance pattern suggests an inevitable catastrophe requiring continuous monitoring and implementation of effective antibiotic stewardship.Entities:
Mesh:
Substances:
Year: 2022 PMID: 35995932 PMCID: PMC9395395 DOI: 10.1038/s41598-022-18595-w
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.996
Number of tests conducted.
| Test | Female | Male | Total number | Percentage (%) |
|---|---|---|---|---|
| Blood | 8 | 4 | 12 | 3.6 |
| Cervical | 6 | – | 6 | 1.8 |
| HVS | 89 | – | 89 | 26.9 |
| Pleural | 1 | – | 1 | 0.3 |
| Semen | – | 1 | 1 | 0.3 |
| Stool | 9 | 8 | 17 | 5.1 |
| Throat | – | 1 | 1 | 0.3 |
| Urethral | 1 | 13 | 14 | 4.2 |
| Urine | 100 | 69 | 169 | 51.1 |
| Wound | 12 | 9 | 21 | 6.3 |
| Total | 226 (68.3%) | 105 (31.7%) | 331 | 100 |
Figure 1Type and frequency of microorganisms isolated from the patient visiting the health facility.
Prevalence of Microorganisms in samples.
| Microbe | Number of samples of tests within which microbes were identified | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Blood | Cervical | HVS | Pleural | Semen | Stool | Throat | Urethra | Urine | Wound | |
| 1 | 24 | – | – | – | – | – | 8 | – | ||
| – | 7 | – | – | – | – | – | 10 | 1 | ||
| – | – | – | – | – | – | – | – | 6 | ||
| – | 6 | – | – | – | – | – | – | – | ||
| 1 | 7 | – | – | – | – | – | 23 | – | ||
| – | – | – | – | – | – | – | 1 | – | ||
| – | 3 | – | – | – | – | – | – | – | ||
| – | – | – | – | – | – | – | 6 | 1 | ||
| – | – | – | – | – | – | – | 1 | – | ||
| – | 1 | – | – | 1 | – | – | 1 | 1 | ||
| – | – | – | – | – | – | – | – | 5 | ||
| 1 | – | 1 | – | – | – | – | – | – | – | |
| – | 6 | – | – | – | – | – | – | 2 | ||
Figure 2Distribution of different clinical isolates among the various samples.
Figure 3Gender-specific distribution of microbes.
Prevalence of microorganisms among age groups.
| Age | Number of samples | ||
|---|---|---|---|
| Total | Microbe absent | Microbe present | |
| 1–5 | 8 | 7 | 1 |
| 6–15 | 9 | 6 | 3 |
| 16–25 | 51 | 27 | 34 |
| 26–40 | 145 | 96 | 49 |
| 41–60 | 41 | 31 | 10 |
| Above 60 | 67 | 35 | 32 |
Individual bacteria identified in samples per age groups.
| Microbe | Age groups | |||||
|---|---|---|---|---|---|---|
| 1–5 | 6–15 | 16–25 | 26–40 | 41–60 | > 60 | |
| 0 | 0 | 12 | 19 | 1 | 1 | |
| 0 | 2 | 4 | 3 | 2 | 7 | |
| 0 | 0 | 0 | 2 | 3 | 1 | |
| 0 | 0 | 1 | 3 | 1 | 1 | |
| 0 | 2 | 3 | 14 | 2 | 10 | |
| 0 | 0 | 0 | 0 | 1 | 0 | |
| 0 | 0 | 1 | 1 | 0 | 1 | |
| 0 | 0 | 1 | 3 | 0 | 3 | |
| 0 | 0 | 1 | 0 | 0 | 0 | |
| 0 | 0 | 0 | 1 | 0 | 3 | |
| 0 | 0 | 0 | 2 | 1 | 2 | |
| 1 | 0 | 0 | 1 | 0 | 0 | |
| 0 | 0 | 2 | 3 | 0 | 3 | |
Figure 4Prevalence of antimicrobial resistance among the specific microbe isolates.